Two human Burkitt's lymphoma cell lines (HBL-4 and HBL-5) were established individually from two patients with small noncleaved cell lymphoma (Burkitt's type). The HBL-4 cell line is Epstein-Barr virus (EBV)-negative, and the HBL-5 cell line is EBV-positive. Cytogenetically, both cell lines had the
Characterization and comparison of two newly established epstein-barr virus-negative lymphoma B-cell lines: Surface markers, growth characteristics, cytogenetics, and transplantability
โ Scribed by Masafumi Abe; Yoshihiro Nozawa; Haruki Wakasa; Hitoshi Ohno; Shiro Fukuhara
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 822 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Two Epstein-Barr virus (EBV)-negative lymphoma B-cell lines, HBL-1 and HBL-2, were established from a pleural effusion and a lymph node biopsy of two patients with diffuse large cell lymphoma. HBL-1 and H B L 2 showed the characteristics of activated Bcells in B-cell lineage, as did original lymphoma cells. Chromosome analyses revealed that HBGI exhibiting 14q+ marker-positive lymphoid cancer showed a new subclass of 14q32 translocation resulting from a translocation between chromosomes 14 and 16, which had been masked in a complex translocation involving five chromosomes, and that HBL-2 had a 14q+ marker chromosome, the result of an 11;14 translocation It(l1;14)(q13;32)]. Successful heterotransplantation into athymic nude mice demonstrated tumorigenicity of HBL-1 and HBL-2. The transplantability and tumor growth rate of HBG2 were higher and more rapid than those of HBGI. HBL-1 and HBL-2 appear useful for facilitating therapeutic investigations as well as immunologic and oncogenic studies in B-cell lymphomas.
๐ SIMILAR VOLUMES